Related Experiment Video

Updated: Aug 10, 2026

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

The monocyte chemotactic protein-1 -2578G allele is associated with elevated MCP-1 concentrations in cerebrospinal

Scott Letendre1, Jennifer Marquie-Beck, Kumud K Singh

  • 1Department of Medicine, The HIV Neurobehavioral Research Center, 150 West Washington Street, San Diego, CA 92103, USA. sletendre@ucsd.edu

Journal of Neuroimmunology
|December 8, 2004
PubMed

Insights

A specific genetic variation in monocyte chemotactic protein-1 (MCP-1) influences its levels in the central nervous system, impacting HIV neuropathogenesis. This MCP-1 promoter polymorphism affects protein expression in the brain.

Area of Science:

  • Neuroimmunology
  • Virology
  • Genetics

Background:

  • Monocyte chemotactic protein-1 (MCP-1) is implicated as a cofactor in HIV neuropathogenesis.
  • Understanding the factors regulating MCP-1 in the central nervous system (CNS) is crucial for addressing HIV-related neurological complications.

Purpose of the Study:

  • To investigate the relationship between a specific MCP-1 gene polymorphism and its expression levels in cerebrospinal fluid (CSF) of HIV-infected individuals.
  • To determine if this genetic variation influences MCP-1 protein levels within the CNS.

Main Methods:

  • Genotyping of a polymorphism in the MCP-1 promoter (at position -2578/-2518) was performed.
  • MCP-1 protein levels were measured in cerebrospinal fluid (CSF) and plasma from 98 HIV-infected subjects.
  • Statistical analyses were conducted to correlate genotype with MCP-1 expression, adjusting for HIV-related factors.

Main Results:

  • MCP-1 levels in CSF showed a clear association with the MCP-1 genotype: highest in G/G, intermediate in G/A, and lowest in A/A.
  • Plasma MCP-1 levels exhibited a similar trend, becoming significant after adjusting for HIV-related factors.
  • The findings indicate a genotype-dependent regulation of MCP-1 expression in the CNS.

Conclusions:

  • The studied MCP-1 promoter polymorphism significantly influences MCP-1 protein expression within the CNS.
  • This genetic regulation of MCP-1 may play a key role in the mechanisms of HIV neuropathogenesis.
  • Targeting MCP-1 pathways could be a potential therapeutic strategy for HIV-associated neurological disorders.

More Related Videos

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis08:01

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis

Published on: November 17, 2017

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages09:57

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages

Published on: August 12, 2019

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...